Active Src Elevates the Expression of β-Catenin by Enhancement of Cap-Dependent Translation

REFERENCES

• Bienz, M., and H. Clevers. 2000. Linking colorectal cancer to Wnt signaling. Cell 103:311–320.
   PubMed Web of Science ®Google Scholar
• Bowman, T., M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 98:7319–7324.
   PubMed Web of Science ®Google Scholar
• Bromann, P. A., H. Korkaya, and S. A. Courtneidge. 2004. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23:7957–7968.
   PubMed Web of Science ®Google Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell, M., J. Zhurinsky, and A. Ben-Ze'ev. 2002. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Investig. 109:987–991.
   PubMed Web of Science ®Google Scholar
• Ellis, L. M., C. A. Staley, W. Liu, R. Y. Fleming, N. U. Parikh, C. D. Bucana, and G. E. Gallick. 1998. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J. Biol. Chem. 273:1052–1057.
   PubMed Web of Science ®Google Scholar
• Fodde, R., R. Smits, and H. Clevers. 2001. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1:55–67.
   PubMed Web of Science ®Google Scholar
• Frederickson, R. M., K. S. Montine, and N. Sonenberg. 1991. Phosphorylation of eukaryotic translation initiation factor 4E is increased in Src-transformed cell lines. Mol. Cell. Biol. 11:2896–2900.
   PubMedGoogle Scholar
• Gingras, A. C., S. P. Gygi, B. Raught, R. D. Polakiewicz, R. T. Abraham, M. F. Hoekstra, R. Aebersold, and N. Sonenberg. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422–1437.
   PubMed Web of Science ®Google Scholar
• Gingras, A. C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913–963.
   PubMed Web of Science ®Google Scholar
• Gingras, A. C., B. Raught, and N. Sonenberg. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807–826.
   PubMed Web of Science ®Google Scholar
• Irby, R. B., W. Mao, D. Coppola, J. Kang, J. M. Loubeau, W. Trudeau, R. Karl, D. J. Fujita, R. Jove, and T. J. Yeatman. 1999. Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21:187–190.
   PubMed Web of Science ®Google Scholar
• Irby, R. B., and T. J. Yeatman. 2000. Role of Src expression and activation in human cancer. Oncogene 19:5636–5642.
   PubMed Web of Science ®Google Scholar
• Kang, D. E., S. Soriano, M. P. Frosch, T. Collins, S. Naruse, S. S. Sisodia, G. Leibowitz, F. Levine, and E. H. Koo. 1999. Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J. Neurosci. 19:4229–4237.
   PubMed Web of Science ®Google Scholar
• Karni, R., Y. Dor, E. Keshet, O. Meyuhas, and A. Levitzki. 2002. Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. J. Biol. Chem. 277:42919–42925.
   PubMedGoogle Scholar
• Korinek, V., N. Barker, P. J. Morin, D. van Wichen, R. de Weger, K. W. Kinzler, B. Vogelstein, and H. Clevers. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 275:1784–1787.
   PubMed Web of Science ®Google Scholar
• Lazaris-Karatzas, A., K. S. Montine, and N. Sonenberg. 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544–547.
   PubMed Web of Science ®Google Scholar
• Lee, J., T. J. Dull, I. Lax, J. Schlessinger, and A. Ullrich. 1989. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J. 8:167–173.
   PubMed Web of Science ®Google Scholar
• Lee, R. J., C. Albanese, R. J. Stenger, G. Watanabe, G. Inghirami, G. K. Haines III, M. Webster, W. J. Muller, J. S. Brugge, R. J. Davis, and R. G. Pestell. 1999. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem. 274:7341–7350.
   PubMed Web of Science ®Google Scholar
• Li, S., S. Ke, and R. J. Budde. 1996. The C-terminal Src kinase (Csk) is widely expressed, active in HT-29 cells that contain activated Src, and its expression is downregulated in butyrate-treated SW620 cells. Cell Biol. Int. 20:723–729.
   PubMedGoogle Scholar
• Lin, P. H., S. Shenoy, T. Galitski, and D. Shalloway. 1995. Transformation of mouse cells by wild-type mouse c-Src. Oncogene 10:401–405.
   PubMedGoogle Scholar
• Mao, W., R. Irby, D. Coppola, L. Fu, M. Wloch, J. Turner, H. Yu, R. Garcia, R. Jove, and T. J. Yeatman. 1997. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15:3083–3090.
   PubMed Web of Science ®Google Scholar
• Marcotrigiano, J., A. C. Gingras, N. Sonenberg, and S. K. Burley. 1999. Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol. Cell 3:707–716.
   PubMed Web of Science ®Google Scholar
• Matsumoto, T., J. Jiang, K. Kiguchi, L. Ruffino, S. Carbajal, L. Beltran, D. K. Bol, M. P. Rosenberg, and J. DiGiovanni. 2003. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Cancer Res. 63:4819–4828.
   PubMedGoogle Scholar
• Minich, W. B., M. L. Balasta, D. J. Goss, and R. E. Rhoads. 1994. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form. Proc. Natl. Acad. Sci. USA 91:7668–7672.
   PubMed Web of Science ®Google Scholar
• Munemitsu, S., I. Albert, B. Rubinfeld, and P. Polakis. 1996. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol. 16:4088–4094.
   PubMedGoogle Scholar
• Myoui, A., R. Nishimura, P. J. Williams, T. Hiraga, D. Tamura, T. Michigami, G. R. Mundy, and T. Yoneda. 2003. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res. 63:5028–5033.
   PubMed Web of Science ®Google Scholar
• Osherov, N., and A. Levitzki. 1994. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur. J. Biochem. 225:1047–1053.
   PubMedGoogle Scholar
• Papkoff, J. 1997. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J. Biol. Chem. 272:4536–4543.
   PubMed Web of Science ®Google Scholar
• Papkoff, J., B. Rubinfeld, B. Schryver, and P. Polakis. 1996. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol. 16:2128–2134.
   PubMed Web of Science ®Google Scholar
• Penuel, E., and G. S. Martin. 1999. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell 10:1693–1703.
   PubMed Web of Science ®Google Scholar
• Pyronnet, S. 2000. Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem. Pharmacol. 60:1237–1243.
   PubMed Web of Science ®Google Scholar
• Rajasekhar, V. K., A. Viale, N. D. Socci, M. Wiedmann, X. Hu, and E. C. Holland. 2003. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12:889–901.
   PubMed Web of Science ®Google Scholar
• Raught, B., and A. C. Gingras. 1999. eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol. 31:43–57.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J. 2001. Cyclin' round the cell with Rac. Dev. Cell 1:160–161.
   PubMedGoogle Scholar
• Riley, D., N. O. Carragher, M. C. Frame, and J. A. Wyke. 2001. The mechanism of cell cycle regulation by v-Src. Oncogene 20:5941–5950.
   PubMed Web of Science ®Google Scholar
• Rousseau, D., A. C. Gingras, A. Pause, and N. Sonenberg. 1996. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13:2415–2420.
   PubMedGoogle Scholar
• Schindler, T., F. Sicheri, A. Pico, A. Gazit, A. Levitzki, and J. Kuriyan. 1999. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3:639–648.
   PubMed Web of Science ®Google Scholar
• Servant, M. J., E. Giasson, and S. Meloche. 1996. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J. Biol. Chem. 271:16047–16052.
   PubMedGoogle Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522–5527.
   PubMed Web of Science ®Google Scholar
• Sinibaldi, D., W. Wharton, J. Turkson, T. Bowman, W. J. Pledger, and R. Jove. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419–5427.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., M. Jaramillo, Y. L. Liu, T. E. Dever, W. C. Merrick, H. F. Kung, and N. Sonenberg. 1990. Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. New Biol. 2:648–654.
   PubMedGoogle Scholar
• Sonenberg, N., and A. C. Gingras. 1998. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell. Biol. 10:268–275.
   PubMed Web of Science ®Google Scholar
• Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
   PubMed Web of Science ®Google Scholar
• Tsuchiya, N., H. Fukuda, T. Sugimura, M. Nagao, and H. Nakagama. 2002. LRP130, a protein containing nine pentatricopeptide repeat motifs, interacts with a single-stranded cytosine-rich sequence of mouse hypervariable minisatellite Pc-1. Eur. J. Biochem. 269:2927–2933.
   PubMedGoogle Scholar
• van Es, J. H., N. Barker, and H. Clevers. 2003. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev. 13:28–33.
   PubMed Web of Science ®Google Scholar
• Waskiewicz, A. J., J. C. Johnson, B. Penn, M. Mahalingam, S. R. Kimball, and J. A. Cooper. 1999. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol. Cell. Biol. 19:1871–1880.
   PubMed Web of Science ®Google Scholar